|
Volumn 34, Issue 11, 2000, Pages 1238-1242
|
Safety and tolerability of bolus intravenous colistin in acute respiratory exacerbations in adults with cystic fibrosis
a a b b b c |
Author keywords
Colistin; Cystic fibrosis; Intravenous bolus
|
Indexed keywords
COLISTIN;
ADULT;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONCENTRATION RESPONSE;
CYSTIC FIBROSIS;
DISEASE EXACERBATION;
DOSE RESPONSE;
DRUG SAFETY;
DRUG TOLERABILITY;
FEMALE;
FORCED EXPIRATORY VOLUME;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
INJECTION PAIN;
NEPHROTOXICITY;
NEUROTOXICITY;
PHASE 1 CLINICAL TRIAL;
PRIORITY JOURNAL;
ADULT;
ANTI-BACTERIAL AGENTS;
COLISTIN;
CYSTIC FIBROSIS;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
HUMANS;
INFUSIONS, INTRAVENOUS;
INJECTIONS, INTRAVENOUS;
MALE;
PSEUDOMONAS AERUGINOSA;
PSEUDOMONAS INFECTIONS;
RESPIRATORY TRACT INFECTIONS;
|
EID: 0033761572
PISSN: 10600280
EISSN: None
Source Type: Journal
DOI: 10.1345/aph.19370 Document Type: Article |
Times cited : (42)
|
References (20)
|